Top analysts on stock perps · Analyst
Evan Seigerman (BMO Capital): analyst track record on stock perps
Evan Seigerman of BMO Capital on companies with stock perpetual futures: star rating, success rate, price-target accuracy, current calls and the measured perp reaction after each rating.
Stars4.8★
Success58%
Excess return+10.2%
rank#615
Ratings498
ratings on stock perps585
Track record
TipRanks data via FMP| 12 months | 3 years | |
|---|---|---|
| Ratings | 330 | 744 |
| Stock | 52 | 55 |
| Buy / hold / sell | 222 / 97 / 11 | 524 / 193 / 27 |
| Upgrades / downgrades / initiations | 4 / 4 / 7 | 6 / 13 / 13 |
| Price targets hit / missed | 134 / 192 (41%) | 374 / 363 (51%) |
| Avg. return after a rating (TipRanks) | +1.8% | +9.4% |
| Best / worst call | +1,101.0% / -85.0% | +1,101.0% / -85.0% |
After buy calls: median 21-day move +1.1% · vs S&P 500 -0.8% (n = 381) · targets hit within a year 48% (n = 258)
Current calls on stock perps
| Stock | Call | Target | vs last close | Date |
|---|---|---|---|---|
| $GILD Gilead Sciences, Inc. | Buy · Maintained | $174 | +11.5% | Oct 19, 2026 |
| $ABBV AbbVie Inc. | Buy · Maintained | $300 | +5.0% | Oct 12, 2026 |
| $AMGN Amgen Inc. | Hold · Maintained | $415 | -5.5% | Oct 12, 2026 |
| $BIIB Biogen Inc. | Hold · Maintained | $220 | -12.2% | Oct 12, 2026 |
| $BMY Bristol Myers Squibb | Hold · Maintained | $60.00 | -2.4% | Oct 12, 2026 |
| $BNTX BioNTech SE | Hold · Maintained | $105 | +19.2% | Oct 12, 2026 |
| $LLY Eli Lilly and Company | Buy · Maintained | $1,400 | +9.9% | Oct 12, 2026 |
| $MRK Merck & Co., Inc. | Buy · Maintained | $170 | +17.0% | Oct 12, 2026 |
| $NVO Novo Nordisk A/S | Hold · Maintained | $40.00 | +2.4% | Oct 12, 2026 |
| $PFE Pfizer Inc. | Buy · Maintained | $35.00 | +16.6% | Oct 12, 2026 |
| $REGN Regeneron Pharmaceuticals, Inc. | Buy · Maintained | $920 | +14.3% | Oct 12, 2026 |
| $SDGR Schrödinger, Inc. | Buy · Maintained | $30.00 | +26.1% | Oct 12, 2026 |
| $VRTX Vertex Pharmaceuticals | Buy · Maintained | $600 | +14.5% | Oct 12, 2026 |
| $ABCL AbCellera Biologics Inc. | Buy · Maintained | $15.00 | +26.9% | Aug 17, 2026 |
Recent ratings
- Oct 19, 2026 $GILD: Maintained · Buy · $174 · article
- Oct 19, 2026 $GILD: Maintained · Buy · $174
- Oct 12, 2026 $BMY: Maintained · Hold · $60.00 · article
- Oct 12, 2026 $PFE: Maintained · Buy · $35.00 · article
- Oct 12, 2026 $GILD: Maintained · Buy · $174 · article
- Oct 12, 2026 $ABBV: Maintained · Buy · $300 · article
- Oct 12, 2026 $VRTX: Maintained · Buy · $600 · article
- Oct 12, 2026 $BNTX: Maintained · Hold · $105 · article
- Oct 12, 2026 $MRK: Maintained · Buy · $170 · article
- Oct 12, 2026 $REGN: Maintained · Buy · $920 · article
- Oct 12, 2026 $LLY: Maintained · Buy · $1,400 · article
- Oct 12, 2026 $NVO: Maintained · Hold · $40.00 · article
- Oct 12, 2026 $SDGR: Maintained · Buy · $30.00 · article
- Oct 12, 2026 $SDGR: Maintained · Buy · $30.00 · article
- Oct 12, 2026 $AMGN: Maintained · Hold · $415 · article
- Oct 12, 2026 $AMGN: Maintained · Hold · $415 · article
- Oct 12, 2026 $BIIB: Maintained · Hold · $220 · article
- Oct 12, 2026 $BIIB: Maintained · Hold · $220 · article
- Oct 12, 2026 $PFE: Maintained · Buy · $35.00
- Oct 12, 2026 $MRK: Maintained · Buy · $170
Evan Seigerman4.8★ · 58% success · +10.2% excess return · TipRanks data via FMP · Source headlines via TheFly/StreetInsider (FMP). Reaction = venue-median perp move after our detection — an observation, not investment advice.